Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9765152
APP PUB NO 20160222127A1
SERIAL NO

15016330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of treating multiple myeloma or non-hodgkins lymphoma with a pharmaceutical composition comprising an anti-CD38 antibody and bortezomib or carfilzomib is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MORPHOSYS AGLENA-CHRIST-STRASSE 48 82152 MARTINSRIED/PLANEGG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boxhammer, Rainer Aying, DE 18 40
Endell, Jan Munich, DE 20 37
Rojkjaer, Lisa Hedingen, CH 14 42
Samuelsson, Christofer Holzkirchen, DE 4 31
Winderlich, Mark Munich, DE 18 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00